Skip to main content
Gerhard Hildebrandt, MD, Hematology, Columbia, MO

GerhardCarlHildebrandtMDDr. med. habil., FACP

Hematology Columbia, MO

Hematologic Oncology

Professor of Medicine

Dr. Hildebrandt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hildebrandt's full profile

Already have an account?

  • Office

    One Hospital Drive
    Columbia, MO 65212
    Phone+1 573-882-8445
    Fax+1 573-884-6292

Education & Training

  • Johannes Gutenberg University of Mainz Faculty of Medicine
    Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1997

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2022 - 2026
  • KY State Medical License
    KY State Medical License 2014 - 2025
  • LA State Medical License
    LA State Medical License 2009 - 2017
  • UT State Medical License
    UT State Medical License 2012 - 2015

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival in a T-cell Depleted Cohort☆  
    Swati Yalamanchi, Hayder Saeed, Dianna Howard, Gerhard C Hildebrandt, Roger Herzig, Gregory Monohan, ScienceDirect

Abstracts/Posters

  • Lisocabtagene Maraleucel (liso-cel) for Treatment of Second-Line Transplant Noneligible (TNE) Relapsed/Refractory (R/R) Aggressive Non-Hodgkin Lymphoma (NHL): Initial ...
    Gerhard C. Hildebrandt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study
    Gerhard C. Hildebrandt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Includi...
    Gerhard C. Hildebrandt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Ellis Fischel Cancer Center Becomes AACI’s Newest Member
    Ellis Fischel Cancer Center Becomes AACI’s Newest MemberDecember 27th, 2022
  • Siteman to Collaborate with University of Missouri on Cancer Research, with Aim to Improve Care
    Siteman to Collaborate with University of Missouri on Cancer Research, with Aim to Improve CareSeptember 20th, 2022
  • Researchers Discover Potential Treatments for Common Complication Following Bone Marrow Transplant
    Researchers Discover Potential Treatments for Common Complication Following Bone Marrow TransplantFebruary 15th, 2024
  • Join now to see all